{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T19:56:43Z","timestamp":1776455803387,"version":"3.51.2"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,4]]},"DOI":"10.7759\/cureus.85336","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:24:02Z","timestamp":1749043442000},"source":"Crossref","is-referenced-by-count":3,"title":["Fontan-Associated Liver Disease: Predictors of Elevated Liver Stiffness and the Role of Transient Elastography in Long-Term Follow-Up"],"prefix":"10.7759","author":[{"given":"Haruka","family":"Sakae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiroh","family":"Tanoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Mawatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ohki","family":"Taniyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Toyodome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Ijuin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Tabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Ido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.26.3.240","article-title":"Surgical repair of tricuspid atresia","volume":"26","author":"Fontan F","year":"1971","unstructured":"Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971, 26:240-8. 10.1136\/thx.26.3.240","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.07.065","article-title":"40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients","volume":"66","author":"Pundi KN","year":"2015","unstructured":"Pundi KN, Johnson JN, Dearani JA, et al.. 40-year follow-up after the Fontan operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol. 2015, 66:1700-10. 10.1016\/j.jacc.2015.07.065","journal-title":"J Am Coll Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.05.010","article-title":"18 years of the Fontan operation at a single institution: results from 771 consecutive patients","volume":"60","author":"Rogers LS","year":"2012","unstructured":"Rogers LS, Glatz AC, Ravishankar C, et al.. 18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol. 2012, 60:1018-25. 10.1016\/j.jacc.2012.05.010","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2016.04.001","article-title":"Adult patients with Fontan circulation: what we know and how to manage adults with Fontan circulation?","volume":"68","author":"Ohuchi H","year":"2016","unstructured":"Ohuchi H. Adult patients with Fontan circulation: what we know and how to manage adults with Fontan circulation?. J Cardiol. 2016, 68:181-9. 10.1016\/j.jjcc.2016.04.001","journal-title":"J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.886208","article-title":"Long-term management of Fontan patients: the importance of a multidisciplinary approach","volume":"10","author":"Martino D","year":"2022","unstructured":"Martino D, Rizzardi C, Vigezzi S, Guariento C, Sturniolo G, Tesser F, Salvo GD. Long-term management of Fontan patients: the importance of a multidisciplinary approach. Front Pediatr. 2022, 10:886208. 10.3389\/fped.2022.886208","journal-title":"Front Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045597","article-title":"Fontan-associated liver disease: screening, management, and transplant considerations","volume":"142","author":"Emamaullee J","year":"2020","unstructured":"Emamaullee J, Zaidi AN, Schiano T, et al.. Fontan-associated liver disease: screening, management, and transplant considerations. Circulation. 2020, 142:591-604. 10.1161\/CIRCULATIONAHA.120.045597","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13500","article-title":"Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease","volume":"50","author":"Sagawa T","year":"2020","unstructured":"Sagawa T, Kogiso T, Sugiyama H, Hashimoto E, Yamamoto M, Tokushige K. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease. Hepatol Res. 2020, 50:853-62. 10.1111\/hepr.13500","journal-title":"Hepatol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2015.11.014","article-title":"Liver disease in patients after the Fontan operation","volume":"117","author":"Pundi K","year":"2016","unstructured":"Pundi K, Pundi KN, Kamath PS, et al.. Liver disease in patients after the Fontan operation. Am J Cardiol. 2016, 117:456-60. 10.1016\/j.amjcard.2015.11.014","journal-title":"Am J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32406","article-title":"Fontan-associated liver disease","volume":"75","author":"Hilscher MB","year":"2022","unstructured":"Hilscher MB, Wells ML, Venkatesh SK, Cetta F, Kamath PS. Fontan-associated liver disease. Hepatology. 2022, 75:1300-21. 10.1002\/hep.32406","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2016.02.002","article-title":"Fontan-associated liver disease: spectrum of US findings","volume":"85","author":"Bae JM","year":"2016","unstructured":"Bae JM, Jeon TY, Kim JS, Kim S, Hwang SM, Yoo SY, Kim JH. Fontan-associated liver disease: spectrum of US findings. Eur J Radiol. 2016, 85:850-6. 10.1016\/j.ejrad.2016.02.002","journal-title":"Eur J Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.045","article-title":"Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015,\u00a0Washington DC","volume":"70","author":"Daniels CJ","year":"2017","unstructured":"Daniels CJ, Bradley EA, Landzberg MJ, et al.. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015,\u00a0Washington DC. J Am Coll Cardiol. 2017, 70:3173-94. 10.1016\/j.jacc.2017.10.045","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy620","article-title":"The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort","volume":"40","author":"Munsterman ID","year":"2019","unstructured":"Munsterman ID, Duijnhouwer AL, Kendall TJ, et al.. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. Eur Heart J. 2019, 40:1057-68. 10.1093\/eurheartj\/ehy620","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","year":"2021","unstructured":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021, 75.659-89. 10.1016\/j.jhep.2021.05.025","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324243","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","volume":"71","author":"M\u00f3zes FE","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, et al.. Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut. 2022, 71:1006-19. 10.1136\/gutjnl-2021-324243","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12240","article-title":"Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis","volume":"33","author":"Bota S","year":"2013","unstructured":"Bota S, Herkner H, Sporea I, Salzl P, Sirli R, Neghina AM, Peck-Radosavljevic M. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013, 33:1138-47. 10.1111\/liv.12240","journal-title":"Liver Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186660","article-title":"Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: a systematic review and meta-analysis","volume":"12","author":"Xiao H","year":"2017","unstructured":"Xiao H, Shi M, Xie Y, Chi X. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: a systematic review and meta-analysis. PLoS One. 2017, 12:e0186660. 10.1371\/journal.pone.0186660","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000191","article-title":"Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease","volume":"7","author":"Gruneau L","year":"2023","unstructured":"Gruneau L, Kechagias S, Sandstr\u00f6m P, Ekstedt M, Henriksson M. Cost-effectiveness analysis of noninvasive tests to identify advanced fibrosis in non-alcoholic fatty liver disease. Hepatol Commun. 2023, 7:10.1097\/HC9.0000000000000191","journal-title":"Hepatol Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.11.018","article-title":"Liver stiffness is directly influenced by central venous pressure","volume":"52","author":"Millonig G","year":"2010","unstructured":"Millonig G, Friedrich S, Adolf S, et al.. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010, 52:206-10. 10.1016\/j.jhep.2009.11.018","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26631","article-title":"Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: a vascular Doppler and elastography study","volume":"59","author":"Kutty SS","year":"2014","unstructured":"Kutty SS, Peng Q, Danford DA, et al.. Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: a vascular Doppler and elastography study. Hepatology. 2014, 59:251-60. 10.1002\/hep.26631","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2016.05.016","article-title":"Non-invasive assessment of liver fibrosis by magnetic resonance elastography in patients with congenital heart disease undergoing the Fontan procedure and intracardiac repair","volume":"68","author":"Sugimoto M","year":"2016","unstructured":"Sugimoto M, Oka H, Kajihama A, Nakau K, Kuwata S, Kurishima C, Azuma H. Non-invasive assessment of liver fibrosis by magnetic resonance elastography in patients with congenital heart disease undergoing the Fontan procedure and intracardiac repair. J Cardiol. 2016, 68:202-8. 10.1016\/j.jjcc.2016.05.016","journal-title":"J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.02.041","article-title":"Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy?","volume":"209","author":"Agnoletti G","year":"2016","unstructured":"Agnoletti G, Ferraro G, Bordese R, et al.. Fontan circulation causes early, severe liver damage. Should we offer patients a tailored strategy?. Int J Cardiol. 2016, 209:60-5. 10.1016\/j.ijcard.2016.02.041","journal-title":"Int J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2014.04.010","article-title":"Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography","volume":"148","author":"Yoo BW","year":"2014","unstructured":"Yoo BW, Choi JY, Eun LY, Park HK, Park YH, Kim SU. Congestive hepatopathy after Fontan operation and related factors assessed by transient elastography. J Thorac Cardiovasc Surg. 2014, 148:1498-505. 10.1016\/j.jtcvs.2014.04.010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012529","article-title":"Fontan\u2010associated liver disease: spectrum of disease in children and adolescents","volume":"9","author":"Rathgeber SL","year":"2020","unstructured":"Rathgeber SL, Guttman OR, Lee AF, Voss C, Hemphill NM, Schreiber RA, Harris KC. Fontan\u2010associated liver disease: spectrum of disease in children and adolescents. J Am Heart Assoc. 2020, 9:e012529. 10.1161\/JAHA.119.012529","journal-title":"J Am Heart Assoc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-020-02291-5","article-title":"Severity of Fontan-associated liver disease correlates with Fontan hemodynamics","volume":"41","author":"Schleiger A","year":"2020","unstructured":"Schleiger A, Salzmann M, Kramer P, et al.. Severity of Fontan-associated liver disease correlates with Fontan hemodynamics. Pediatr Cardiol. 2020, 41:736-46. 10.1007\/s00246-020-02291-5","journal-title":"Pediatr Cardiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12159","article-title":"Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis","volume":"9","author":"Wu FM","year":"2014","unstructured":"Wu FM, Opotowsky AR, Raza R, et al.. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis. Congenit Heart Dis. 2014, 9:438-47. 10.1111\/chd.12159","journal-title":"Congenit Heart Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101646","article-title":"Characteristics and survival outcomes of hepatocellular carcinoma after the Fontan operation","volume":"4","author":"Rosenthal BE","year":"2025","unstructured":"Rosenthal BE, Hoteit MA, Lluri G, et al.. Characteristics and survival outcomes of hepatocellular carcinoma after the Fontan operation. JACC Adv. 2025, 4:101646. 10.1016\/j.jacadv.2025.101646","journal-title":"JACC Adv"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13892","article-title":"Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines)","volume":"53","author":"Hasegawa K","year":"2023","unstructured":"Hasegawa K, Takemura N, Yamashita T, et al.. Clinical practice guidelines for hepatocellular carcinoma: the Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines). Hepatol Res. 2023, 53:383-90. 10.1111\/hepr.13892","journal-title":"Hepatol Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1055\/a-0641-0076","article-title":"EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version)","volume":"38","author":"Dietrich CF","year":"2017","unstructured":"Dietrich CF, Bamber J, Berzigotti A, et al.. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med. 2017, 38:e48. 10.1055\/a-0641-0076","journal-title":"Ultraschall Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06612.x","article-title":"Biomarkers of liver fibrosis","volume":"26","author":"Adams LA","year":"2011","unstructured":"Adams LA. Biomarkers of liver fibrosis. J Gastroenterol Hepatol. 2011, 26:802-9. 10.1111\/j.1440-1746.2010.06612.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.644","article-title":"Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure","volume":"18","author":"Biegus J","year":"2016","unstructured":"Biegus J, Zymli\u0144ski R, Sokolski M, et al.. Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure. Eur J Heart Fail. 2016, 18:1518-21. 10.1002\/ejhf.644","journal-title":"Eur J Heart Fail"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13627","article-title":"Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure","volume":"51","author":"Cho Y","year":"2021","unstructured":"Cho Y, Kabata D, Ehara E, et al.. Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure. Hepatol Res. 2021, 51:593-602. 10.1111\/hepr.13627","journal-title":"Hepatol Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128","author":"Cast\u00e9ra L","year":"2005","unstructured":"Cast\u00e9ra L, Vergniol J, Foucher J, et al.. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005, 128:343-50. 10.1053\/j.gastro.2004.11.018","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/chd.12446","article-title":"Surveillance for liver complications after the Fontan procedure","volume":"12","author":"Hilscher MB","year":"2017","unstructured":"Hilscher MB, Johnson JN, Cetta F, et al.. Surveillance for liver complications after the Fontan procedure. Congenit Heart Dis. 2017, 12:124-32. 10.1111\/chd.12446","journal-title":"Congenit Heart Dis"},{"key":"ref34","article-title":"Cirrhosis: diagnosis and management","volume":"100","author":"Smith A","year":"2019","unstructured":"Smith A, Baumgartner K, Bositis C. Cirrhosis: diagnosis and management. Am Fam Physician. 2019, 100:759-70.","journal-title":"Am Fam Physician"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/978-4-431-68361-2_15","article-title":"Ultrasonography in the Diagnosis of Portal Hypertension","volume":"Springer","author":"Matsutani S","year":"1991","unstructured":"Matsutani S, Kimura K, Ohto M, Okuda K`. Ultrasonography in the Diagnosis of Portal Hypertension. Portal hypertension: clinical and physiological aspects. 1991, Springer:Tokyo. 10.1007\/978-4-431-68361-2_15","journal-title":"Portal hypertension: clinical and physiological aspects"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong VW","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, et al.. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010, 51:454-62. 10.1002\/hep.23312","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23312.38","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong VWS","year":"2010","unstructured":"Wong VWS, Vergniol J, Wong GLH, et al.. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010, 51:454-62. 10.1002\/hep.23312.38","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2017.00015","article-title":"Non-invasive investigations for the diagnosis of Fontan-associated liver disease in pediatric and adult Fontan patients","volume":"4","author":"Fidai A","year":"2017","unstructured":"Fidai A, Dallaire F, Alvarez N, et al.. Non-invasive investigations for the diagnosis of Fontan-associated liver disease in pediatric and adult Fontan patients. Front Cardiovasc Med. 2017, 4:15. 10.3389\/fcvm.2017.00015","journal-title":"Front Cardiovasc Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1100514","article-title":"Fontan-associated liver disease: diagnosis, surveillance, and management","volume":"11","author":"de Lange C","year":"2023","unstructured":"de Lange C, M\u00f6ller T, Hebelka H. Fontan-associated liver disease: diagnosis, surveillance, and management. Front Pediatr. 2023, 11:1100514. 10.3389\/fped.2023.1100514","journal-title":"Front Pediatr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.12.017","article-title":"Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults","volume":"56","author":"Jarasvaraparn C","year":"2024","unstructured":"Jarasvaraparn C, Thoe J, Rodenbarger A, Masuoka H, Payne RM, Markham LW, Molleston JP. Biomarkers of fibrosis and portal hypertension in Fontan-associated liver disease in children and adults. Dig Liver Dis. 2024, 56:1335-42. 10.1016\/j.dld.2023.12.017","journal-title":"Dig Liver Dis"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100362","article-title":"Non-invasive biomarkers of Fontan-associated liver disease","volume":"3","author":"Emamaullee J","year":"2021","unstructured":"Emamaullee J, Khan S, Weaver C, et al.. Non-invasive biomarkers of Fontan-associated liver disease. JHEP Rep. 2021, 3:100362. 10.1016\/j.jhepr.2021.100362","journal-title":"JHEP Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2022-321435","article-title":"Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease","volume":"109","author":"Martin de Miguel I","year":"2023","unstructured":"Martin de Miguel I, Kamath PS, Egbe AC, Jain CC, Cetta F, Connolly HM, Miranda WR. Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease. Heart. 2023, 109:619-25. 10.1136\/heartjnl-2022-321435","journal-title":"Heart"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100249","article-title":"From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?","volume":"3","author":"Sessa A","year":"2021","unstructured":"Sessa A, Allaire M, Lebray P, Medmoun M, Tiritilli A, Iaria P, Cadranel JF. From congestive hepatopathy to hepatocellular carcinoma, how can we improve patient management?. JHEP Rep. 2021, 3:100249. 10.1016\/j.jhepr.2021.100249","journal-title":"JHEP Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs440","article-title":"What does the liver tell us about the failing heart?","volume":"34","author":"Auer J","year":"2013","unstructured":"Auer J. What does the liver tell us about the failing heart?. Eur Heart J. 2013, 34:711-4. 10.1093\/eurheartj\/ehs440","journal-title":"Eur Heart J"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8100117","article-title":"Role of transient elastography to stage Fontan-associated liver disease (FALD) in adults with single ventricle congenital heart disease correction","volume":"8","author":"Chemello L","year":"2021","unstructured":"Chemello L, Padalino M, Zanon C, Benvegnu' L, Biffanti R, Mancuso D, Cavalletto L. Role of transient elastography to stage Fontan-associated liver disease (FALD) in adults with single ventricle congenital heart disease correction. J Cardiovasc Dev Dis. 2021, 8:10.3390\/jcdd8100117","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004809","article-title":"Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study","volume":"6","author":"Goldberg DJ","year":"2017","unstructured":"Goldberg DJ, Surrey LF, Glatz AC, et al.. Hepatic fibrosis is universal following Fontan operation, and severity is associated with time from surgery: a liver biopsy and hemodynamic study. J Am Heart Assoc. 2017, 6:10.1161\/JAHA.116.004809","journal-title":"J Am Heart Assoc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2016.10.060","article-title":"Liver health in adults with Fontan circulation: a multicenter cross-sectional study","volume":"153","author":"Wu FM","year":"2017","unstructured":"Wu FM, Kogon B, Earing MG, et al.. Liver health in adults with Fontan circulation: a multicenter cross-sectional study. J Thorac Cardiovasc Surg. 2017, 153:656-64. 10.1016\/j.jtcvs.2016.10.060","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2016.07.006","article-title":"Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation","volume":"57","author":"Surrey LF","year":"2016","unstructured":"Surrey LF, Russo P, Rychik J, et al.. Prevalence and characterization of fibrosis in surveillance liver biopsies of patients with Fontan circulation. Hum Pathol. 2016, 57:106-15. 10.1016\/j.humpath.2016.07.006","journal-title":"Hum Pathol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14093","article-title":"Importance of gamma-glutamyl transferase elevation in patients with Fontan-associated liver disease","volume":"54","author":"Kogiso T","year":"2024","unstructured":"Kogiso T, Ogasawara Y, Taniai M, Shimada E, Inai K, Tokushige K, Nakai Y. Importance of gamma-glutamyl transferase elevation in patients with Fontan-associated liver disease. Hepatol Res. 2024, 54:1205-14. 10.1111\/hepr.14093","journal-title":"Hepatol Res"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270230","article-title":"Risk factors for Fontan-associated hepatocellular carcinoma","volume":"17","author":"Kogiso T","year":"2022","unstructured":"Kogiso T, Sagawa T, Taniai M, Shimada E, Inai K, Shinohara T, Tokushige K. Risk factors for Fontan-associated hepatocellular carcinoma. PLoS One. 2022, 17:e0270230. 10.1371\/journal.pone.0270230","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2012.09.005","article-title":"Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis","volume":"146","author":"Johnson JA","year":"2013","unstructured":"Johnson JA, Cetta F, Graham RP, Smyrk TC, Driscoll DJ, Phillips SD, John AS. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis. J Thorac Cardiovasc Surg. 2013, 146:140-5. 10.1016\/j.jtcvs.2012.09.005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivw186","article-title":"Liver stiffness modifications shortly after total cavopulmonary connection","volume":"23","author":"Deorsola L","year":"2016","unstructured":"Deorsola L, Aidala E, Cascarano MT, Valori A, Agnoletti G, Pace Napoleone C. Liver stiffness modifications shortly after total cavopulmonary connection. Interact Cardiovasc Thorac Surg. 2016, 23:513-8. 10.1093\/icvts\/ivw186","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2011.08.038","article-title":"Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study","volume":"143","author":"Schwartz MC","year":"2012","unstructured":"Schwartz MC, Sullivan L, Cohen MS, et al.. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study. J Thorac Cardiovasc Surg. 2012, 143:904-9. 10.1016\/j.jtcvs.2011.08.038","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1181-9","article-title":"Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma","volume":"42","author":"Wells ML","year":"2017","unstructured":"Wells ML, Hough DM, Fidler JL, Kamath PS, Poterucha JT, Venkatesh SK. Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. Abdom Radiol (NY). 2017, 42:2623-31. 10.1007\/s00261-017-1181-9","journal-title":"Abdom Radiol (NY)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/365997-fontan-associated-liver-disease-predictors-of-elevated-liver-stiffness-and-the-role-of-transient-elastography-in-long-term-follow-up","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T13:24:03Z","timestamp":1749043443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/365997-fontan-associated-liver-disease-predictors-of-elevated-liver-stiffness-and-the-role-of-transient-elastography-in-long-term-follow-up"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":54,"URL":"https:\/\/doi.org\/10.7759\/cureus.85336","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}